Evaluation of DecisionDx®-SCC Genetic Panel Validity using CDC's ACCE Criteria

Published: 10 May 2024| Version 1 | DOI: 10.17632/5xs74kbx9d.1
Contributors:
, Christopher McFarland, Bryan Carroll

Description

This material details the comparison of the DecisionDx®-SCC 40-GEP genetic panel against the CDC's ACCE criteria for clinical genetic tests. It applies the original 44 ACCE criteria to the genetic test.

Files

Institutions

  • Case Western Reserve University

Categories

Dermatology, Squamous Cell Carcinoma, Genetic Testing

Licence